Christina M Lam1, Ksenya Shliakhtsitsava2, Shaylyn S Stark3, Alexa C O Medica1, Kelsey A Pinson1, Brian W Whitcomb4, H Irene Su5. 1. Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California. 2. Department of Pediatric Hematology/Oncology, University of Texas Southwestern, Dallas, Texas. 3. Moores Cancer Center, University of California, San Diego, La Jolla, California. 4. Department of Biostatistics and Epidemiology, School of Public Health & Health Sciences, University of Massachusetts, Amherst, Massachusetts. 5. Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California; Moores Cancer Center, University of California, San Diego, La Jolla, California. Electronic address: hisu@ucsd.edu.
Abstract
OBJECTIVE: To examine the association between prior cancer treatments, medical comorbidities, and voluntary childlessness in reproductive-age women who are survivors of cancers diagnosed as adolescents and young adults (AYA survivors). DESIGN: Cross-sectional analysis. SETTING: Participants were recruited from California and Texas cancer registries, fertility preservation programs, and cancer advocacy groups. PATIENT(S): Women (n = 413) ages 18-40 who were diagnosed with cancer between ages 15 and 35, completed primary cancer treatments, had at least one ovary, and were nulliparous. INTERVENTION(S): Cancer treatment gonadotoxicity and medical comorbidities. MAIN OUTCOME MEASURE(S): Voluntary childlessness. RESULT(S): The mean age of survivors was 31.8 years (SD, 4.9) with a mean of 6.5 years (SD, 4.4) since cancer diagnosis. Breast (26%), thyroid (19%), and Hodgkin lymphoma (18%) were the most common cancers. Twenty-two percent of the cohort was voluntarily childless. Medical comorbidities, cancer diagnosis, prior surgery, prior chemotherapy, and prior gonadotoxic treatments were not significantly associated with voluntary childlessness. In adjusted analysis, survivors of older reproductive age (adjusted odds ratio = 2.97 [1.71-5.18]) and nonheterosexual participants (adjusted odds ratio = 4.71 [2.15-10.32]) were more likely to report voluntary childlessness. CONCLUSION(S): A moderate proportion of AYA cancer survivors are voluntarily childless, but reproductive intentions were not related to cancer type or cancer treatments. AYA survivors of older age and nonheterosexual identification were more likely to be voluntarily childless. These data support assessing reproductive intentions and tailoring reproductive care such as fertility and contraception counseling that is appropriate for a survivor's intentions.
OBJECTIVE: To examine the association between prior cancer treatments, medical comorbidities, and voluntary childlessness in reproductive-age women who are survivors of cancers diagnosed as adolescents and young adults (AYA survivors). DESIGN: Cross-sectional analysis. SETTING:Participants were recruited from California and Texas cancer registries, fertility preservation programs, and cancer advocacy groups. PATIENT(S): Women (n = 413) ages 18-40 who were diagnosed with cancer between ages 15 and 35, completed primary cancer treatments, had at least one ovary, and were nulliparous. INTERVENTION(S): Cancer treatment gonadotoxicity and medical comorbidities. MAIN OUTCOME MEASURE(S): Voluntary childlessness. RESULT(S): The mean age of survivors was 31.8 years (SD, 4.9) with a mean of 6.5 years (SD, 4.4) since cancer diagnosis. Breast (26%), thyroid (19%), and Hodgkin lymphoma (18%) were the most common cancers. Twenty-two percent of the cohort was voluntarily childless. Medical comorbidities, cancer diagnosis, prior surgery, prior chemotherapy, and prior gonadotoxic treatments were not significantly associated with voluntary childlessness. In adjusted analysis, survivors of older reproductive age (adjusted odds ratio = 2.97 [1.71-5.18]) and nonheterosexual participants (adjusted odds ratio = 4.71 [2.15-10.32]) were more likely to report voluntary childlessness. CONCLUSION(S): A moderate proportion of AYA cancer survivors are voluntarily childless, but reproductive intentions were not related to cancer type or cancer treatments. AYA survivors of older age and nonheterosexual identification were more likely to be voluntarily childless. These data support assessing reproductive intentions and tailoring reproductive care such as fertility and contraception counseling that is appropriate for a survivor's intentions.
Authors: Samantha C Roberts; Amber Knight; Brian W Whitcomb; Jessica R Gorman; Andrew C Dietz; H Irene Su Journal: J Cancer Surviv Date: 2017-03-06 Impact factor: 4.442
Authors: R Sankila; J H Olsen; H Anderson; S Garwicz; E Glattre; H Hertz; F Langmark; M Lanning; T Møller; H Tulinius Journal: N Engl J Med Date: 1998-05-07 Impact factor: 91.245
Authors: Lari Wenzel; Aysun Dogan-Ates; Rana Habbal; Ross Berkowitz; Donald P Goldstein; Marilyn Bernstein; Brenda Coffey Kluhsman; Kathryn Osann; Edward Newlands; Michael J Seckl; Barry Hancock; David Cella Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: S Alwan; I M Yee; M Dybalski; C Guimond; E Dwosh; T M Greenwood; R Butler; A D Sadovnick Journal: Mult Scler Date: 2012-07-03 Impact factor: 6.312
Authors: Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Wendy van Dorp; Riccardo Haupt; Richard A Anderson; Renee L Mulder; Marry M van den Heuvel-Eibrink; Eline van Dulmen-den Broeder; H Irene Su; Jeanette Falck Winther; Melissa M Hudson; Jennifer M Levine; W Hamish Wallace Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Alexandra C Himelhoch; Taylor M Datillo; Marrit A Tuinman; Cynthia A Gerhardt; Vicky Lehmann Journal: J Adolesc Young Adult Oncol Date: 2021-05-17 Impact factor: 2.223
Authors: Natalie V Scime; Erin Hetherington; Amy Metcalfe; Kathleen H Chaput; Sandra M Dumanski; Cynthia H Seow; Erin A Brennand Journal: CMAJ Open Date: 2022-04-05